Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
-- Takeda submits application for TAK-019/NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for NDA, to Japan's Ministry of Health, Labour and Welfare (MHLW) -- Interim data from Phase 1/2 trial in Japan demonstrate robust immune response and favorable tolerability with no serious adverse events GAITHERSBURG, Md., Dec. 16, 2021 /PRNewswire/ --...
Ascentage Pharma Announces 2021 Annual Results with Commercialization Programs Going Full Steam Ahead
SUZHOU, China and ROCKVILLE, Md., March. 21, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for full year 2021, during which the company achieved significant progress realizing its vision of global innovation...
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment
SHANGHAI and GAITHERSBURG, Md., March 31, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Company's key shareholders including CBC Group (including its affiliates) and Hony Capital (collectively, the "Key Shareholders") as well as its senior...
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
Opus™, the operating platform for Industry 4.0, provides the infrastructure to predict drug shortages by applying Artificial Intelligence to analyze the movement of more than 30 billion products tracked within the world's largest Healthcare and Life Sciences network. BOSTON, April 5, 2022 /PRNewswire/ -- TraceLink Inc, the leading digital network platform company,...
Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting
FLORENCE, Italy and NEW YORK, May 9, 2023 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics ("Stemline"), a wholly-owned subsidiary of the Menarini Group, announced today that they will present new data related to elacestrant in upcoming congresses. Elacestrant has been approved by the...
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the Only Immunoassay Analyzer with No Daily Maintenancei NT-proBNP Assay Now Available...
Leading New Zealand cancer research ‘super-charged’ by data privacy startup
DUNEDIN, New Zealand, May 25, 2023 /PRNewswire/ -- Two top medical research and biotech innovators today announce a partnership that will supercharge cancer research while providing new levels of health data privacy. Amaroq Therapeutics, a world-leading company based in New Zealand focused on developing a new class of therapeutics that targets long non-coding RNA in cancer, is elevating its research...
Neurophet to unveil brain image analysis technology related to treatment of Alzheimer’s disease at AAIC 2023
- New brain image analysis solution for Alzheimer's disease treatment is planned to be commercialized along with the release of treatment - In discussion with global big pharma companies for collaboration at AAIC SEOUL, South Korea, July 18, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced...
Ubie Won the “Best with AI” in Google Play Best of 2023 (Japan)
NEW YORK, Dec. 16, 2023 /PRNewswire/ -- Ubie, Inc., headquartered at 1460 Broadway, New York, NY 10036 and led by CEO Kota Kubo, proudly announces that the Japanese version of Ubie's AI Symptom Checker (https://ubie.app/) has been awarded the "Best with AI" at the Google Play Best of 2023. This prestigious recognition precedes Ubie's forthcoming launch of the Android...
Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India
DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its new DNA/RNA Shield - DirectDetect™ reagent and collection devices to Mapmygenome™ based in Hyderabad, India....
